VU seeks reputational gains, greater awareness of research, more diversity.
Former BioMimetic Therapeutics executives at center of new initiatives.
Frontier Capital, Petra Capital, TextRequest, CEAdvisory raise, Pharos Cap, VU Med Innovators, MDSave.
[Updated] Team says rapid Angel-investor enlistment is one reason this is a 'W' for region's LifeSciences
The past two FY's have seen VU IP embedded in startups in several sectors.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: